Intrinsic Value

The intrinsic value of AbL Diagnostics SA (9BK0) under the Base Case is 2.6 EUR per share. Compared with the current market price of 2.84 EUR, the stock appears Overvalued by 8% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

9BK0 Intrinsic Value
€2.6
Overvaluation 8%
Intrinsic Value
Price €2.84

We don’t have enough historical valuation data to make this comparison.

Monitor 9BK0
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €2.08
Get notified when the price drops into your buy zone
Current Price €2.84
Intrinsic Value €2.6
Margin of Safety 20% €2.08
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to 9BK0

Fundamental Analysis

What AbL Diagnostics Does

Trading Companies & Distributors Industrials

AbL Diagnostics SA makes molecular diagnostic tests for laboratories and hospitals. Its products help customers detect infectious diseases and identify the genetic markers that can affect how a patient is treated. The company sells the test kits, reagents, and related lab products needed to run these analyses.

Headquarters
France FR
IPO date
Mar 25, 1991
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
AbL Diagnostics SA

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one 9BK0 stock?

The intrinsic value for AbL Diagnostics SA (9BK0) under the Base Case is 2.6 EUR.

Is 9BK0 stock undervalued or overvalued?

Compared with the current market price of 2.84 EUR, the stock appears Overvalued by 8% .

Back to Top